Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association.

Levine GN, Lange RA, Bairey-Merz CN, Davidson RJ, Jamerson K, Mehta PK, Michos ED, Norris K, Ray IB, Saban KL, Shah T, Stein R, Smith SC Jr; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Hypertension.

J Am Heart Assoc. 2017 Sep 28;6(10). pii: e002218. doi: 10.1161/JAHA.117.002218.

2.

Association Between Mind-Body Practice and Cardiometabolic Risk Factors: The Rotterdam Study.

Younge JO, Leening MJ, Tiemeier H, Franco OH, Kiefte-de Jong J, Hofman A, Roos-Hesselink JW, Hunink MG.

Psychosom Med. 2015 Sep;77(7):775-83. doi: 10.1097/PSY.0000000000000213.

PMID:
26186434
3.

The physiological basis of complementary and alternative medicines for polycystic ovary syndrome.

Raja-Khan N, Stener-Victorin E, Wu X, Legro RS.

Am J Physiol Endocrinol Metab. 2011 Jul;301(1):E1-E10. doi: 10.1152/ajpendo.00667.2010. Epub 2011 Apr 12. Review. Erratum in: Am J Physiol Endocrinol Metab. 2012 Dec 15;303(12):E1506.

4.

Effects of yoga and meditation on clinical and biochemical parameters of metabolic syndrome.

Khatri D, Mathur KC, Gahlot S, Jain S, Agrawal RP.

Diabetes Res Clin Pract. 2007 Dec;78(3):e9-10. Epub 2007 Jun 26. No abstract available.

PMID:
17597249
5.

Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease.

Paul-Labrador M, Polk D, Dwyer JH, Velasquez I, Nidich S, Rainforth M, Schneider R, Merz CN.

Arch Intern Med. 2006 Jun 12;166(11):1218-24.

PMID:
16772250

Supplemental Content

Loading ...
Support Center